Myasthenic Syndrome Caused by Hydroxychloroquine Used for COVID-19 Prophylaxis
Güray Koç, Zeki Odabaşı, Ersin Tan
Abstract
*Department of Neurology, Gulhane Research and Training Hospital, Ankara, Turkey †Department of Neurology, Neuromuscular Diseases Research Laboratory, Hacettepe University, Ankara, Turkey The authors report no conflicts of interest.
Topics & Concepts
MedicineHydroxychloroquineCoronavirus disease 2019 (COVID-19)NeurologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakFamily medicineVirologyInternal medicinePsychiatryOutbreakDiseaseInfectious disease (medical specialty)Peripheral Neuropathies and DisordersMyasthenia Gravis and ThymomaDrug-Induced Ocular Toxicity